Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 2
2006 2
2007 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 3
2014 3
2015 3
2016 2
2017 6
2018 2
2019 6
2020 4
2021 2
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic Approaches in Malignant Pleural Mesothelioma.
Terenziani R, Zoppi S, Fumarola C, Alfieri R, Bonelli M. Terenziani R, et al. Among authors: bonelli m. Cancers (Basel). 2021 Jun 4;13(11):2793. doi: 10.3390/cancers13112793. Cancers (Basel). 2021. PMID: 34199722 Free PMC article. Review.
Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
Coccè V, Bonelli M, La Monica S, Alfieri R, Doneda L, Martegani E, Alessandri G, Lagrasta CA, Giannì A, Sordi V, Petrella F, Roncoroni L, Paino F, Pessina A. Coccè V, et al. Among authors: bonelli m. Biochem Pharmacol. 2023 Aug;214:115678. doi: 10.1016/j.bcp.2023.115678. Epub 2023 Jul 1. Biochem Pharmacol. 2023. PMID: 37399948 Free article.
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.
Fumarola C, Bonelli MA, Petronini PG, Alfieri RR. Fumarola C, et al. Among authors: bonelli ma. Biochem Pharmacol. 2014 Aug 1;90(3):197-207. doi: 10.1016/j.bcp.2014.05.011. Epub 2014 May 24. Biochem Pharmacol. 2014. PMID: 24863259 Review.
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.
Galvani E, Alfieri R, Giovannetti E, Cavazzoni A, La Monica S, Galetti M, Fumarola C, Bonelli M, Mor M, Tiseo M, Peters GJ, Petronini PG, Ardizzoni A. Galvani E, et al. Among authors: bonelli m. Curr Pharm Des. 2013;19(5):818-32. Curr Pharm Des. 2013. PMID: 22973953 Review.
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Digiacomo G, Fumarola C, La Monica S, Bonelli M, Cavazzoni A, Galetti M, Terenziani R, Eltayeb K, Volta F, Zoppi S, Bertolini P, Missale G, Alfieri R, Petronini PG. Digiacomo G, et al. Among authors: bonelli m. Front Oncol. 2022 Jul 22;12:942341. doi: 10.3389/fonc.2022.942341. eCollection 2022. Front Oncol. 2022. PMID: 35936714 Free PMC article.
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice.
La Monica S, Coccé V, Bonelli M, Alessandri G, Alfieri R, Lagrasta CA, Frati C, Flammini L, Gianni A, Petrella F, Paino F, Pessina A. La Monica S, et al. Among authors: bonelli m. Curr Cancer Drug Targets. 2023;23(8):663-668. doi: 10.2174/1568009623666230201092302. Curr Cancer Drug Targets. 2023. PMID: 36722476 Free article.
54 results